WallStreetZenWallStreetZen

NASDAQ: CSTL
Castle Biosciences Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Castle Biosciences earnings were $18.2M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CSTL earnings report on Dec 31, 2024 announced Q4 2024 earnings of $9.6M, up 322.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CSTL reported annual earnings of $18.2M, with -131.7% growth.

CSTL past earnings growth

How has CSTL's earnings growth performed historically?

Company
N/A
Industry
0%
Market
64.34%
CSTL's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CSTL's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

CSTL earnings history

Current Revenue
$332.1M
Current Earnings
$18.2M
Current Profit Margin
5.5%

CSTL Return on Equity

Current Company
4.2%
Current Industry
-10.9%
Current Market
34.1%
CSTL's Return on Equity (4.2%)... subscribe to Premium to read more.
High Return on Equity Performance

CSTL undefined

Current Company
3.7%
Current Industry
5.7%
CSTL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CSTL announces earnings.

CSTL undefined

Current Company
4.6%
Current Industry
9.7%
CSTL has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CSTL vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CSTL$38.14M$18.25M+13.53%$0.66
FLGT-$22.33M-$42.71MN/A-$1.41
MYGN-$50.00M-$127.30MN/A-$1.41
LAB-$112.37M-$184.90MN/A-$0.52
PSNL-$68.90M-$81.28MN/A-$1.37
View Top Diagnostic & Research Stocks

Castle Biosciences Earnings Reports & History FAQ

What were Castle Biosciences's earnings last quarter?

On CSTL's earnings call on Invalid Date, Castle Biosciences (NASDAQ: CSTL) reported Q4 2024 earnings per share (EPS) of $0.35, up 488.89% year over year. Total CSTL earnings for the quarter were $9.59 million. In the same quarter last year, Castle Biosciences's earnings per share (EPS) was -$0.09.

If you're new to stock investing, here's how to buy Castle Biosciences stock.

Is Castle Biosciences profitable or losing money?

As of the last Castle Biosciences earnings report, Castle Biosciences is currently profitable. Castle Biosciences's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $18.25 million, a 131.75% decrease year over year.

What was CSTL's earnings growth in the past year?

As of Castle Biosciences's earnings date in Invalid Date, Castle Biosciences's earnings has grown year over year. CSTL earnings in the past year totalled $18.25 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.